Literature DB >> 3262661

Cell-mediated immune response toward viral envelope and core antigens in gibbon apes (Hylobates lar) chronically infected with human immunodeficiency virus-1.

P Lusso1, P D Markham, A Ranki, P Earl, B Moss, F Dorner, R C Gallo, K J Krohn.   

Abstract

The specific cellular immune response toward envelope and core proteins of human immunodeficiency virus-1 (HIV-1) was investigated in gibbon apes chronically infected with the HTLV-IIIB isolate. After in vitro stimulation of PBMC from infected and control animals with HIV-1 Ag, DNA synthesis, IL-2R expression and IL-2 release were assayed. Cells from infected gibbon apes demonstrated a group-specific response toward whole virus preparations from three divergent HIV-1 isolates (HTLV-IIIB, HTLV-IIIRF, HTLV-IIIMN). Consistent responses were also detected against purified HIV-1 Ag, i.e., native gp120 envelope glycoprotein, recombinant gp160 glycoprotein, a synthetic peptide (peptide 7) representing a highly conserved region of gp120, and purified native core protein p24. In addition, lymphocytes from infected gibbon apes displayed a specific, MHC-restricted, cytotoxic activity against autologous cells expressing HIV-1 envelope or gag proteins. The specific T cell reactivity toward HIV-1 proteins observed in infected gibbons contrasts with findings in HIV-1 infected humans, and may help to explain the apparent discrepancy in the natural history of the infection between the two species.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3262661

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Generation of a chimeric human and simian immunodeficiency virus infectious to monkey peripheral blood mononuclear cells.

Authors:  R Shibata; M Kawamura; H Sakai; M Hayami; A Ishimoto; A Adachi
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

2.  The inability of human immunodeficiency virus to infect chimpanzee monocytes can be overcome by serial viral passage in vivo.

Authors:  H E Gendelman; G D Ehrlich; L M Baca; S Conley; J Ribas; D C Kalter; M S Meltzer; B J Poiesz; P Nara
Journal:  J Virol       Date:  1991-07       Impact factor: 5.103

3.  Species-specific, postentry barriers to primate immunodeficiency virus infection.

Authors:  W Hofmann; D Schubert; J LaBonte; L Munson; S Gibson; J Scammell; P Ferrigno; J Sodroski
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

4.  In vitro susceptibility of T lymphocytes from chimpanzees (Pan troglodytes) to human herpesvirus 6 (HHV-6): a potential animal model to study the interaction between HHV-6 and human immunodeficiency virus type 1 in vivo.

Authors:  P Lusso; P D Markham; S E DeRocco; R C Gallo
Journal:  J Virol       Date:  1990-06       Impact factor: 5.103

5.  Development of AIDS in a chimpanzee infected with human immunodeficiency virus type 1.

Authors:  F J Novembre; M Saucier; D C Anderson; S A Klumpp; S P O'Neil; C R Brown; C E Hart; P C Guenthner; R B Swenson; H M McClure
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

6.  Serological, biological, and molecular characterization of New Zealand white rabbits infected by intraperitoneal inoculation with cell-free human immunodeficiency virus.

Authors:  S Reina; P Markham; E Gard; F Rayed; M Reitz; R C Gallo; O E Varnier
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

7.  Polymorphism of human and primate RANTES, CX3CR1, CCR2 and CXCR4 genes with regard to HIV/SIV infection.

Authors:  Bénédicte Puissant; Michel Abbal; Antoine Blancher
Journal:  Immunogenetics       Date:  2003-07-23       Impact factor: 2.846

8.  Tissue-specific expression of human CD4 in transgenic mice.

Authors:  F P Gillespie; L Doros; J Vitale; C Blackwell; J Gosselin; B W Snyder; S C Wadsworth
Journal:  Mol Cell Biol       Date:  1993-05       Impact factor: 4.272

9.  An infectious chimeric human immunodeficiency virus type 2 (HIV-2) expressing the HIV-1 principal neutralizing determinant.

Authors:  M Mamounas; D J Looney; R Talbott; F Wong-Staal
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Human topoisomerase I promotes HIV-1 proviral DNA synthesis: implications for the species specificity and cellular tropism of HIV-1 infection.

Authors:  Yuko Shoya; Kenzo Tokunaga; Hirofumi Sawa; Masae Maeda; Tomonori Ueno; Tomoki Yoshikawa; Hideki Hasegawa; Tetsutaro Sata; Takeshi Kurata; William W Hall; Bryan R Cullen; Hidehiro Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-26       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.